1. De novo ssRNA Aptamers against the SARS-CoV-2 Main Protease: In Silico Design and Molecular Dynamics Simulation
- Author
-
Ilaria Tortorella, Francesco Morena, Sabata Martino, Chiara Argentati, and Carla Emiliani
- Subjects
0301 basic medicine ,medicine.medical_treatment ,Entropy ,viruses ,single strand RNA aptamer ,medicine.disease_cause ,01 natural sciences ,Molecular Docking Simulation ,Aptamers ,Single-Stranded ,Biology (General) ,skin and connective tissue diseases ,Spectroscopy ,Coronavirus ,010304 chemical physics ,Chemistry ,virus diseases ,General Medicine ,Aptamers, Nucleotide ,Computer Science Applications ,aptamer-protein free energy calculation ,aptamers virtual screening ,Nucleotide ,QH301-705.5 ,Aptamer ,In silico ,DNA, Single-Stranded ,Computational biology ,Molecular Dynamics Simulation ,Catalysis ,Article ,Inorganic Chemistry ,Viral Matrix Proteins ,03 medical and health sciences ,TheoryofComputation_ANALYSISOFALGORITHMSANDPROBLEMCOMPLEXITY ,0103 physical sciences ,medicine ,Physical and Theoretical Chemistry ,Binding site ,Molecular Biology ,QD1-999 ,Viral matrix protein ,Protease ,Binding Sites ,SARS-CoV-2 ,Organic Chemistry ,fungi ,RNA ,COVID-19 ,DNA ,prediction of 3D RNA aptamer structure ,body regions ,aptamer-protein interaction ,030104 developmental biology ,Drug Design - Abstract
Herein, we have generated ssRNA aptamers to inhibit SARS-CoV-2 Mpro, a protease necessary for the SARS-CoV-2 coronavirus replication. Because there is no aptamer 3D structure currently available in the databanks for this protein, first, we modeled an ssRNA aptamer using an entropic fragment-based strategy. We refined the initial sequence and 3D structure by using two sequential approaches, consisting of an elitist genetic algorithm and an RNA inverse process. We identified three specific aptamers against SARS-CoV-2 Mpro, called MAptapro, MAptapro-IR1, and MAptapro-IR2, with similar 3D conformations and that fall in the dimerization region of the SARS-CoV-2 Mpro necessary for the enzymatic activity. Through the molecular dynamic simulation and binding free energy calculation, the interaction between the MAptapro-IR1 aptamer and the SARS-CoV-2 Mpro enzyme resulted in the strongest and the highest stable complex, therefore, the ssRNA MAptapro-IR1 aptamer was selected as the best potential candidate for the inhibition of SARS-CoV-2 Mpro and a perspective therapeutic drug for the COVID-19 disease.
- Published
- 2021